Program
Thursday, October 15, 2020
Friday, October 16, 2020
Saturday, October 17, 2020
Sunday, October 18, 2020
Thursday, October 15, 2020
Opening Keynote Session
6-7 p.m.
Metabolic regulation of tumor differentiation
Stephen B. Baylin, Johns Hopkins University School of Medicine, Baltimore, Maryland
Opening Reception
7-8:30 p.m.
Friday, October 16, 2020
Continental Breakfast
7-8 a.m.
Plenary Session 1: Cancer and Epigenetics
8-10 a.m.
Metabolic regulation of cancer cell fate
Lydia W.S. Finley, Memorial Sloan Kettering Cancer Center, New York, New York
The epigenetics of cancer
Peter A. Jones, Van Andel Institute, Grand Rapids, Michigan
2 additional speakers to be announced
Plenary Session 2: Differentiation and Metabolism
10:30 a.m.-12:30 p.m.
Title to be announced
Olivier Pourquié, Harvard Medical School/Brigham and Women’s Hospital, Boston, Massachusetts
Title to be announced
Tony Hunter, Salk Institute, La Jolla, California
Title to be announced
Heather R. Christofk, University of California Los Angeles, Los Angeles, California
2 short talks from proffered abstracts
Free Time / Lunch on Own
12:30-2:30 p.m.
Plenary Session 3: Epigenetics and Tumor Metabolism 1
2:30-4:30 p.m.
Acetyl-CoA metabolism and chromatin modification
Kathryn E. Wellen, University of Pennsylvania, Philadelphia, Pennsylvania
Title to be announced
Shelley L. Berger, University of Pennsylvania, Philadelphia, Pennsylvania
Epigenetic underpinnings of metabolic disease heterogeneity
J. Andrew Pospisilik, Van Andel Institute, Grand Rapids, Michigan
2 short talks from proffered abstracts
Poster Session A / Reception
4:30-7 p.m.
Saturday, October 17, 2020
Continental Breakfast
7-8 a.m.
Plenary Session 4: Epigenetics and Tumor Metabolism 2
8-10 a.m.
Title to be announced
Kimberly Stegmaier, Dana-Farber Cancer Institute, Boston, Massachusetts
Decoding the regulation and function of transcriptional master regulators in cancer metabolism
Johannes Zuber, Research Institute of Molecular Pathology, Vienna, Austria
Viral mimicry in stem cells and cancer
Andreas Trumpp, German Cancer Research Center (DKFZ), Heidelberg, Germany
2 short talks from proffered abstracts
Break
10-10:30 a.m.
Plenary Session 5: Cancer Immunometabolism
10:30 a.m.-12:30 p.m.
Title to be announced
Jonathan D. Powell, Johns Hopkins School of Medicine, Baltimore, Maryland
Title to be announced
Ayelet Erez, Weizmann Institute of Science, Rehovot, Israel
Mitochondria control adaptive immunity
Navdeep S. Chandel, Northwestern University, Chicago, Illinois
2 short talks from proffered abstracts
Poster Session B / Lunch
12:30-3 p.m.
Plenary Session 6: in Vivo Cancer Metabolism
3-5 p.m.
Title to be announced
Ralph J. DeBerardinis, UT Southwestern, Dallas, Texas
Title to be announced
Teresa W.M. Fan, University of Kentucky, Lexington, Kentucky
Metabolism revisited
Joshua D. Rabinowitz, Princeton University, Princeton, New Jersey
Title to be announced
David A. Mankoff, University of Pennsylvania, Philadelphia, Pennsylvania
Sunday, October 18, 2020
Continental Breakfast
7-8 a.m.
Plenary Session 7: Stem Cell Maintenance
8-9:30 a.m.
Title to be announced
Omer Yilmaz, Koch Institute of Integrative Cancer at MIT, Cambridge, Massachusetts
Title to be announced
Sean J. Morrison, UT Southwestern, Dallas, Texas
Additional speaker to be announced
2 short talks from proffered abstracts
Plenary Session 8: Emerging Concepts
10 a.m.-12 p.m.
Title to be announced
Matthew G. Vander Heiden, Koch Institute for Integrative Cancer Research at MIT, Cambridge, Massachusetts
Metabolic zonation in glioblastoma dictates phenotypic diversification of tumor cells
Eli Keshet, Hebrew University of Jerusalem, Jerusalem, Israel
Clock-HIF signaling in the epigenetic control of glucose metabolism
Clara Bien Peek, Northwestern University, Chicago, Illinois
2 short talks from proffered abstracts